Clinical Conduct Associates have achieved the ISO (International Organization for Standardization) 9001:2008 certification from Certification Europe. Clinical Conduct Associates is one of a select number of companies to meet the stringent ISO 9001:2008 certification requirements.

The ISO 9001:2008 certification demonstrates Clinical Conduct Associates commitment to quality in the provision of their innovative clinical trial management services in Phase I-IV clinical trials to the pharmaceutical, biotechnology and device industries worldwide.

In accepting the registration certificate, David Hall, Director of Clinical research at CCA, "Achieving and maintaining the ISO 9001:2008 certification requires continuous process improvement aimed at providing total customer satisfaction. The team at CCA are focused on continuously developing and delivering reliable innovative and quality services in the clinical trial industry for all our clients. Clinical Conduct Associates success is the direct result of a high level of dedication to achieving total customer satisfaction through unsurpassed service, on-time delivery, that exceeds our customers' expectations for quality and performance."

ISO 9001:2008 is the latest version of ISO 9001 and is the internationally recognized standard for a quality management system which focuses on an organization's actions to meet and continually improve customer satisfaction and quality requirements.

This accreditation has been achieved through graduate placement as a joint partnership between the University of Ulster through Intertrade Irelands fusion project. Fusion is an Intertrade Ireland initiative that aims to help your business to develop and implement new technologies, systems or processes and as such improve capabilities in innovation, design and technology for services provided.










Clinical Conduct Associates took centre stage in Dublin last night when Irelands most Innovative research and development business projects were showcased at The Irish Times All-island Innovation awards in association with InterTradeIreland.

Clinical Conduct Associates were shortlisted in as a finalist in the North South collaboration category and were present at the awards to showcase its internationally recognized clinical trial management services with an emphasis on their quality management alignment services which were developed as a joint partnership between the University of Ulster through Intertrade Irelands fusion project.

Liam Nellis, Chief Executive of InterTradeIreland, commented during the evening that: "Innovation is critical to the future of both economies on the island, North and South. Now, more than ever, businesses need an innovative and enterprising culture for commercial success and growth.

To stand out from a field of 120 entries, each shortlisted companies had to prove their ability to innovate and advance and to be shortlisted as a finalist in the competition was recognition of the innovative services that Clinical Conduct Associates provide to the pharmaceutical, biotech and medical devices industries worldwide makes us very proud and happy.










Clinical Conduct Associates has been shortlisted once again in the Small Firms Association National Small Business Awards in the 'Innovator of the Year' category. Again this year CCA was recognised by SFA for its achievements, and excellence in the provision of its innovative clinical trials services to the pharmaceutical and biotechnology industry worldwide.










Clinical Conduct Associates has been shortlisted as a finalist in the Small Firms Association National Small Business Awards in the 'Outstanding Small Business of the Year' category.

The SFA National Small Business Awards are commonly recognised as a valuable medium for Irish small business to promote their organisation and in return receive recognition for achievement, innovation and excellence, therefore CCA is extremely happy to find ourselves among the very few companies on the shortlist for the Awards. At the Awards ceremony in the Mansion House in Dublin we received commendation by an Taoiseach Bertie Ahern for our achievements to date within our industry for such a small company. He also highlighted the importance of the provision of innovative services to the Irish biotechnology and pharmaceutical industry which remains an important sector in Ireland for the provision of large scale employment and thanked CCA for its help in providing crucial services to the sector.